The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...
The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.
Zacks Investment Research on MSN
Silver economy boom: Investing in healthcare's aging tailwinds
An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...
The Global Prefilled Auto Injectors Market is projected to grow at a CAGR of 8.4% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
At the conference, first-ever accuracy and performance data will be presented for Dexcom's upcoming G7 15 Day system,1 showing an overall mean absolute relative difference (MARD) of 8.0%, making ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. AARP’s Medicare experts share tips and updates to help manage ...
More than 160 miles of new rail, bus and other fixed-guideway transit lines opened in the U.S. in 2025, and about 94 miles more are projected to be completed this year, according to data from The ...
The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first smart MDI system to automatically integrate insulin dosing and glucose data ...
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results